MedPath

Physical Exercise for Treatment of Depression and Anxiety - RCT

Not Applicable
Active, not recruiting
Conditions
Anxiety
Depression
Interventions
Other: Relaxation Therapy
Other: Physical Exercise
Registration Number
NCT04714528
Lead Sponsor
Region Örebro County
Brief Summary

In a 12 week randomly controlled open trial 102 participants with symptoms of depression and/or anxiety will be exposed to either aerobic high intensity training (HIT) or relaxation therapy. Cognitive functions, biomarkers, psychiatric symptom scales and physical status will be collected at baseline, after 12 weeks and after a year. Depression and anxiety will be measured twice during the intervention period.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
87
Inclusion Criteria
  • Score ≥12 on MADRS or score ≥16 on BAI
  • Inhabitant i Örebro County, Sweden
  • BMI ≥18 kg/m^2
Exclusion Criteria
  • Diagnosis of chronic psychotic disease or ongoing psychotic episode.
  • Ongoing manic state of bipolar disorder
  • Severe somatic disease or condition where high intensity exercise is contraindicated
  • Difficulty with reading, hearing or understanding the Swedish language

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Relaxation GroupRelaxation Therapy45 minutes of relaxation therapy once per week for 12 weeks.
Physical Exercise GroupPhysical Exercise45 minutes of aerobic, high intensity group training, three times per week during a 12-week period.
Primary Outcome Measures
NameTimeMethod
Symptom improvement in anxietyChange of the score from the baseline to the score at 1 year.

Improvement of symptom severity grade are assessed with Beck Anxiety Inventory (BAI). The minimum and the maximum score is 0 and 63 respectively, and the higher score means a worse outcome.

Symptom improvement in depressionChange of the score from the baseline to the score at 1 year.

Improvement of symptom severity grade are assessed with Montgomery-Åsberg Depression Rating Scale (MADRS). The minimum and the maximum score is 0 and 60 respectively, and the higher score means a worse outcome.

Subjective symptom improvement in depressionChange of the score from the baseline to the score at 1 year.

Improvement of symptom severity grade are assessed with Montgomery-Åsberg Depression Rating Scale Self-Rating Version (MADRS-S). The minimum and the maximum score is 0 and 60 respectively, and the higher score means a worse outcome.

Secondary Outcome Measures
NameTimeMethod
Cognitive function: Trail Making Test Part A&BComparison of results between baseline and year 1.

Cognitive functions are measured using digitized cognitive tests selected for depression in cooperation with Mindmore.

Cognitive function: Corsi Block-Tapping Test forwardComparison of results between baseline and year 1.

Cognitive functions are measured using digitized cognitive tests selected for depression in cooperation with Mindmore.

Cognitive function: Rey Auditory Verbal Learning TestComparison of results between baseline and year 1.

Cognitive functions are measured using digitized cognitive tests selected for depression in cooperation with Mindmore.

Cognitive function: Stroop testComparison of results between baseline and year 1.

Cognitive functions are measured using digitized cognitive tests selected for depression in cooperation with Mindmore.

Clinical Global Impression (CGI) severity scaleUp to 1 year from baseline.

Clinician's impression of total severity of the mental illness. Scale between 0 and 7, higher point indicates worse outcome.

EuroQol-Health-Related Quality of Life (EQ-5D-5L)Up to 1 year from baseline.

Assesses the current overall health related to wellbeing and function experienced by the patient.

The questionnaire consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.

The EQ visual analogue scale (EQ VAS) records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine' between 0 and 100. The higher point indicates better outcome.

Posttraumatic Stress Disorder Checklist (PCL-5)Up to 1 year from baseline.

Measures symptoms in posttraumatic stress disorder. Total points 0-80, higher point indicates worse outcome.

Adult ADHD Self-Report Scale (ASRS)Up to 1 year from baseline.

Measures symptoms in attention deficiency and hyperactivity disorder (ADHD). Minimum 0 point to maximum 72 points. Higher point indicates worse outcome.

Cognitive function: Symbol Digit Modalities TestComparison of results between baseline and year 1.

Cognitive functions are measured using digitized cognitive tests selected for depression in cooperation with Mindmore.

Perceived Stress Scale (PSS-14)Up to 1 year from baseline.

Measures perceived stress. Minimum 0 point to maximum 56 points. Higher point indicates worse outcome.

Trial Locations

Locations (1)

Department of Psychiatry, University hospital Örebro

🇸🇪

Örebro, Sweden

© Copyright 2025. All Rights Reserved by MedPath